LLMpediaThe first transparent, open encyclopedia generated by LLMs

cytochrome P450

Generated by DeepSeek V3.2
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: indinavir Hop 3
Expansion Funnel Raw 91 → Dedup 67 → NER 11 → Enqueued 11
1. Extracted91
2. After dedup67 (None)
3. After NER11 (None)
Rejected: 56 (not NE: 56)
4. Enqueued11 (None)
cytochrome P450
NameCytochrome P450
EC number1.14.14.1
CAS number9035-51-2

cytochrome P450. Cytochrome P450 enzymes are a large and ubiquitous superfamily of heme-containing monooxygenases found across all domains of life. These metalloenzymes are primarily membrane-associated, often located in the endoplasmic reticulum or mitochondrial inner membrane of eukaryotes. They are critically important for the oxidative metabolism of a vast array of both endogenous and exogenous compounds, playing central roles in steroidogenesis, bile acid synthesis, and the detoxification of foreign chemicals.

Structure and classification

The characteristic feature of all cytochrome P450 proteins is a conserved heme prosthetic group where the central iron atom is coordinated by a cysteine thiolate ligand. This unique coordination is responsible for the distinctive Soret absorption band at 450 nm when reduced and complexed with carbon monoxide. The overall tertiary structure is highly conserved, typically consisting of a helical bundle domain and a beta-sheet rich region that creates a substrate access channel. The P450 Nomenclature Committee classifies these enzymes based on amino acid sequence identity into families (designated by a number, e.g., CYP3) and subfamilies (designated by a letter, e.g., CYP2D), with individual isozymes given a final number.

Enzymatic function and mechanism

Cytochrome P450 enzymes catalyze monooxygenation reactions, most commonly inserting one atom of molecular oxygen into a substrate while reducing the other to water. The general stoichiometry requires NADPH and the associated flavoprotein NADPH-cytochrome P450 reductase as an electron donor in the endoplasmic reticulum system. The catalytic cycle involves a series of steps: substrate binding, first electron reduction, oxygen binding, second electron reduction, and finally oxygen–oxygen bond cleavage and product formation. Key reaction types include aliphatic hydroxylation, aromatic hydroxylation, N-dealkylation, O-dealkylation, and epoxidation.

Biological roles and significance

In mammals, these enzymes are indispensable for numerous physiological processes. They are essential for the biosynthesis of steroid hormones such as estradiol, testosterone, and cortisol in organs like the adrenal gland and gonads. They are crucial for the synthesis of cholesterol-derived bile acids in the liver and for the metabolism of vitamin D and retinoic acid. In plants, they are involved in the synthesis of lignin, alkaloids, and various phytoalexins. In many bacteria, including Streptomyces, they participate in the production of antibiotics.

Genetic diversity and evolution

The cytochrome P450 superfamily is one of the largest and oldest known, with genes present in archaea, bacteria, fungi, plants, and animals. This diversity arose through multiple events of gene duplication and subsequent divergent evolution, often driven by environmental pressures such as exposure to new plant toxins. The Human Genome Project has identified 57 functional CYP genes in humans, with notable polymorphisms in enzymes like CYP2C9 and CYP2C19. Comparative studies of Drosophila and C. elegans P450s have provided significant insights into their evolutionary history and functional diversification.

Clinical and pharmacological relevance

These enzymes are the principal agents of Phase I metabolism for an estimated 75% of all clinically used pharmaceutical drugs, including agents like warfarin, omeprazole, and many antiretroviral drugs. Consequently, drug–drug interactions often occur via enzyme inhibition or enzyme induction of key isoforms like CYP3A4. Genetic variations, such as those in CYP2D6, can create poor metabolizer or ultrarapid metabolizer phenotypes, dramatically affecting drug efficacy and toxicity, a cornerstone of pharmacogenomics. Their role in activating procarcinogens like polycyclic aromatic hydrocarbons and aflatoxin B1 also links them to chemical carcinogenesis. Category:Enzymes Category:Metabolism Category:Pharmacology